1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 CFTR
  • 1.2.3 Mucolytics
  • 1.2.4 PERT
  • 1.2.5 Anti-infectives
  • 1.2.6 Bronchodilators
• 1.3 Market by Application
  • 1.3.1 Global Cystic Fibrosis Therapeutics Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cystic Fibrosis Therapeutics Market Perspective (2015-2026)
• 2.2 Global Cystic Fibrosis Therapeutics Growth Trends by Regions
  • 2.2.1 Cystic Fibrosis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cystic Fibrosis Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cystic Fibrosis Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cystic Fibrosis Therapeutics Players by Market Size
  • 3.1.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2015-2020)
• 3.2 Global Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Cystic Fibrosis Therapeutics Revenue
• 3.4 Global Cystic Fibrosis Therapeutics Market Concentration Ratio
  • 3.4.1 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Therapeutics Revenue in 2019
• 3.5 Key Players Cystic Fibrosis Therapeutics Area Served
• 3.6 Key Players Cystic Fibrosis Therapeutics Product Solution and Service
• 3.7 Date of Enter into Cystic Fibrosis Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cystic Fibrosis Therapeutics Breakdown Data by Type (2015-2026)

• 4.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2021-2026)

5 Cystic Fibrosis Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Application (2015-2020)
• 5.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cystic Fibrosis Therapeutics Market Size (2015-2026)
• 6.2 North America Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
• 6.3 North America Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)
• 6.4 North America Cystic Fibrosis Therapeutics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Cystic Fibrosis Therapeutics Market Size (2015-2026)
• 7.2 Europe Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
• 7.3 Europe Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)
• 7.4 Europe Cystic Fibrosis Therapeutics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Cystic Fibrosis Therapeutics Market Size (2015-2026)
• 8.2 China Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
• 8.3 China Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)
• 8.4 China Cystic Fibrosis Therapeutics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Cystic Fibrosis Therapeutics Market Size (2015-2026)
• 9.2 Japan Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
• 9.3 Japan Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)
• 9.4 Japan Cystic Fibrosis Therapeutics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Cystic Fibrosis Therapeutics Market Size (2015-2026)
• 10.2 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Cystic Fibrosis Therapeutics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Vertex Pharmaceuticals
  • 11.1.1 Vertex Pharmaceuticals Company Details
  • 11.1.2 Vertex Pharmaceuticals Business Overview
  • 11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
  • 11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2015-2020))
  • 11.1.5 Vertex Pharmaceuticals Recent Development
• 11.2 F. Hoffmann-La Roche
  • 11.2.1 F. Hoffmann-La Roche Company Details
  • 11.2.2 F. Hoffmann-La Roche Business Overview
  • 11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Introduction
  • 11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.2.5 F. Hoffmann-La Roche Recent Development
• 11.3 AbbVie
  • 11.3.1 AbbVie Company Details
  • 11.3.2 AbbVie Business Overview
  • 11.3.3 AbbVie Cystic Fibrosis Therapeutics Introduction
  • 11.3.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.3.5 AbbVie Recent Development
• 11.4 Gilead Sciences
  • 11.4.1 Gilead Sciences Company Details
  • 11.4.2 Gilead Sciences Business Overview
  • 11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Introduction
  • 11.4.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.4.5 Gilead Sciences Recent Development
• 11.5 Novartis
  • 11.5.1 Novartis Company Details
  • 11.5.2 Novartis Business Overview
  • 11.5.3 Novartis Cystic Fibrosis Therapeutics Introduction
  • 11.5.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.5.5 Novartis Recent Development
• 11.6 AstraZeneca
  • 11.6.1 AstraZeneca Company Details
  • 11.6.2 AstraZeneca Business Overview
  • 11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Introduction
  • 11.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.6.5 AstraZeneca Recent Development
• 11.7 Bayer
  • 11.7.1 Bayer Company Details
  • 11.7.2 Bayer Business Overview
  • 11.7.3 Bayer Cystic Fibrosis Therapeutics Introduction
  • 11.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.7.5 Bayer Recent Development
• 11.8 Celtaxsys
  • 11.8.1 Celtaxsys Company Details
  • 11.8.2 Celtaxsys Business Overview
  • 11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Introduction
  • 11.8.4 Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.8.5 Celtaxsys Recent Development
• 11.9 Pharmaxis
  • 11.9.1 Pharmaxis Company Details
  • 11.9.2 Pharmaxis Business Overview
  • 11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Introduction
  • 11.9.4 Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.9.5 Pharmaxis Recent Development
• 11.10 ProQR Therapeutics
  • 11.10.1 ProQR Therapeutics Company Details
  • 11.10.2 ProQR Therapeutics Business Overview
  • 11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Introduction
  • 11.10.4 ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 11.10.5 ProQR Therapeutics Recent Development
• 11.11 PTC Therapeutics
  • 10.11.1 PTC Therapeutics Company Details
  • 10.11.2 PTC Therapeutics Business Overview
  • 10.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Introduction
  • 10.11.4 PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 10.11.5 PTC Therapeutics Recent Development
• 11.12 Alcresta Therapeutics
  • 10.12.1 Alcresta Therapeutics Company Details
  • 10.12.2 Alcresta Therapeutics Business Overview
  • 10.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Introduction
  • 10.12.4 Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 10.12.5 Alcresta Therapeutics Recent Development
• 11.13 Insmed Incorporated
  • 10.13.1 Insmed Incorporated Company Details
  • 10.13.2 Insmed Incorporated Business Overview
  • 10.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Introduction
  • 10.13.4 Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 10.13.5 Insmed Incorporated Recent Development
• 11.14 Savara
  • 10.14.1 Savara Company Details
  • 10.14.2 Savara Business Overview
  • 10.14.3 Savara Cystic Fibrosis Therapeutics Introduction
  • 10.14.4 Savara Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 10.14.5 Savara Recent Development
• 11.15 Cyclacel Pharmaceuticals
  • 10.15.1 Cyclacel Pharmaceuticals Company Details
  • 10.15.2 Cyclacel Pharmaceuticals Business Overview
  • 10.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
  • 10.15.4 Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 10.15.5 Cyclacel Pharmaceuticals Recent Development
• 11.16 Vectura
  • 10.16.1 Vectura Company Details
  • 10.16.2 Vectura Business Overview
  • 10.16.3 Vectura Cystic Fibrosis Therapeutics Introduction
  • 10.16.4 Vectura Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 10.16.5 Vectura Recent Development
• 11.17 Allergan
  • 10.17.1 Allergan Company Details
  • 10.17.2 Allergan Business Overview
  • 10.17.3 Allergan Cystic Fibrosis Therapeutics Introduction
  • 10.17.4 Allergan Revenue in Cystic Fibrosis Therapeutics Business (2015-2020)
  • 10.17.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Cystic Fibrosis Therapeutics Scope and Market Size
Cystic Fibrosis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cystic Fibrosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators

Market segment by Application, split into
Hospitals
Clinics

Based on regional and country-level analysis, the Cystic Fibrosis Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Cystic Fibrosis Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
ProQR Therapeutics
PTC Therapeutics
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals
Vectura
Allergan